234 related articles for article (PubMed ID: 197886)
21. Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus.
Cohen GH
J Virol; 1972 Mar; 9(3):408-18. PubMed ID: 4335659
[TBL] [Abstract][Full Text] [Related]
22. Cytopathogenicity, drug susceptibility, and thymidine kinase activity of a retinovirulent herpes simplex virus type 2.
Langford MP; Colacino JM; Kaiwar R; Mahjoub SB; Ganley JP
J Med Virol; 1990 Aug; 31(4):301-5. PubMed ID: 2176674
[TBL] [Abstract][Full Text] [Related]
23. Biological properties of equine herpesvirus type 1 DNA: transfectivity and transforming capacity.
Allen GP; Randall CC
Infect Immun; 1978 Oct; 22(1):34-40. PubMed ID: 215545
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
Machida H; Sakata S; Morozumi M; Kiyanagi T; Kuninaka A; Yoshino H
Antiviral Res; 1982 Sep; 2(4):217-26. PubMed ID: 6293376
[TBL] [Abstract][Full Text] [Related]
25. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
[TBL] [Abstract][Full Text] [Related]
26. The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication.
Neyts J; Andrei G; Snoeck R; Jähne G; Winkler I; Helsberg M; Balzarini J; De Clercq E
Antimicrob Agents Chemother; 1994 Dec; 38(12):2710-6. PubMed ID: 7695251
[TBL] [Abstract][Full Text] [Related]
27. Induction of deoxythymidine kinase activity in several mammalian cell lines after infection with six different strains of equine herpesvirus type 1 (EHV-1).
Allen GP; McGowan JJ; Bryans JT; Randall CC; Gentry GA
Virology; 1978 Oct; 90(2):351-9. PubMed ID: 214953
[No Abstract] [Full Text] [Related]
28. The effect of a methyl or 2-fluoroethyl substituent at the N-3 position of thymidine, 3'-fluoro-3'-deoxythymidine and 1-beta-D-arabinosylthymine on their antiviral and cytostatic activity in cell culture.
Balzarini J; Celen S; Karlsson A; de Groot T; Verbruggen A; Bormans G
Antivir Chem Chemother; 2006; 17(1):17-23. PubMed ID: 16542002
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
[TBL] [Abstract][Full Text] [Related]
31. Thymidine kinase (TK) activity in herpes simplex virus type 1 recombinants that carry insertions affecting regulation of the TK gene.
Tenser RB; Edris WA
Virology; 1986 Nov; 155(1):257-61. PubMed ID: 3022474
[TBL] [Abstract][Full Text] [Related]
32. Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells.
Kong XB; Scheck AC; Price RW; Vidal PM; Fanucchi MP; Watanabe KA; Fox JJ; Chou TC
Antiviral Res; 1988 Dec; 10(4-5):153-66. PubMed ID: 2852483
[TBL] [Abstract][Full Text] [Related]
33. Deoxyribonucleoside triphosphate pools in synchronized human cells infected with herpes simplex virus types 1 and 2.
Roller B; Cohen GH
J Virol; 1976 Apr; 18(1):58-64. PubMed ID: 176471
[TBL] [Abstract][Full Text] [Related]
34. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
Honess RW; O'Hare P; Young D
J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
[TBL] [Abstract][Full Text] [Related]
35. Adenylic acid: deoxythymidine 5'-phosphotransferase: evidence for the existence of a novel herpes simplex virus-induced enzyme.
Falke D; Nehrbass W; Brauer D; Müller WE
J Gen Virol; 1981 Apr; 53(Pt 2):247-55. PubMed ID: 6267178
[TBL] [Abstract][Full Text] [Related]
36. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of herpes simplex virus type 2 replication by thymidine.
Cohen GH; Factor MN; Ponce de Leon M
J Virol; 1974 Jul; 14(1):20-5. PubMed ID: 4365718
[TBL] [Abstract][Full Text] [Related]
38. Alterations in substrate specificity and physicochemical properties of deoxythymidine kinase of a drug-resistant herpes simplex virus type 1 mutant.
Veerisetty V; Gentry GA
J Virol; 1983 Jun; 46(3):901-8. PubMed ID: 6304349
[TBL] [Abstract][Full Text] [Related]
39. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. II. DNA and protein synthesis, polypeptide processing and transport.
Dargan DJ; Subak-Sharpe JH
J Gen Virol; 1986 Sep; 67 ( Pt 9)():1831-50. PubMed ID: 3018126
[TBL] [Abstract][Full Text] [Related]
40. Thymidine kinase deletion mutants of herpes simplex virus type 1.
Sanders PG; Wilkie NM; Davison AJ
J Gen Virol; 1982 Dec; 63(2):277-95. PubMed ID: 6296278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
